P21 Rekombinanter Antikörper
P21 Rekombinant Antikörper für WB, IF/ICC, IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IF/ICC, IP, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3N14
Kat-Nr. : 82669-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
82669-2-PBS bindet in WB, IF/ICC, IP, Indirect ELISA P21 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | P21 fusion protein Ag0368 |
| Vollständiger Name | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| Berechnetes Molekulargewicht | 18 kDa |
| Beobachtetes Molekulargewicht | 21 kDa |
| GenBank-Zugangsnummer | BC000275 |
| Gene symbol | p21 |
| Gene ID (NCBI) | 1026 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported.









